XTend Medical to Begin Pilot Program With Australian Physician Group; Global Demand for Remote Diabetic Patient Monitoring on the Upswing

SUN VALLEY, Calif., June 2 /PRNewswire-FirstCall/ -- XTend Medical Corporation announced today the company will begin a Pilot Program with a large hospital group in Australia. The initial program will encompass 20 patients with a total target of 150-500 patients by the end of 2008.

"I'm extremely excited about this opportunity to place our product with a physician group outside the U.S. Our continued marketing efforts have really paid off. We have seen a tremendous amount of interest in our product since the 1st of the year and we plan to close as many of these leads as we can from a global prospective. This, coupled with imminent closing of several large managed care contracts here in the U.S. over the next few months, insures the company will have solid growth not only here domestically but also in the global telemedicine markets. We've received inquiries for our product from over 12 different countries to date and our recent advertisement in Executive Healthcare Magazine has produced over 300 leads from health organizations and physicians looking to monitor their diabetic patients remotely. XTend Medical will work hard to close these leads and place our product into the hands of as many healthcare agencies as we can in order to allow both the patient and physician to raise the level of care in managing diabetes care," stated Mr. Paul D. Lisenby, CEO of XTend Medical.

The recent issue of Executive Healthcare highlights Elias Zerhouni's articles on diabetes and can be viewed at http://www.executivehm.com/currentissue/currentissues.asp

For any healthcare agency of physician group that would like to find more about the how XTend can assist in the remote management of diabetic patients, please visit the company website at www.xtendmedical.com or email us at info@xtendmedical.com

About XTend Medical: XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. XTend has developed a complete Remote Diabetic Patient Monitoring System that is currently being used by physicians and other healthcare agencies throughout the U.S. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. For more information, please visit their website at www.xtendmedical.com

Safe Harbor

This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.

CONTACT: FutureTechIR, +1-817-812-2105, for XTend Medical Corporation

Web site: http://www.xtendmedical.com/

MORE ON THIS TOPIC